The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease
Open accessAbstract
Background: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa.Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response.We hypothesized that dysregulated microRNA (miRNA) expression may contribute to IBD pathogenesis.miRNAs are small, non-coding RNAs which prevent protein synthesis through translational suppression or mRNAs degradation, and regulate several physiological processes.Methodology/Findings: Expression of mature miRNAs was studied by Q-PCR in inactive colonic mucosa of patients with UC (8), CD (8) and expressed relative to that observed in healthy controls (10).Only miRNAs with highly altered expression (.5 or ,0.2 -fold relative to control) were considered when Q-PCR data were analyzed.Two subsets of 14 (UC) and 23 (CD) miRNAs with highly altered expression (5.2-.100 -fold and 0.05-0.19-fold for over-and under-expression, respectively; 0.001,p#0.05)were identified in quiescent colonic mucosa, 8 being commonly dysregulated in non-inflamed UC and CD (mir-26a,-29a,-29b,-30c,-126*,-127-3p,-196a,-324-3p).Several miRNA genes with dysregulated expression co-localize with acknowledged IBD-susceptibility loci while others, (eg.clustered on 14q32.31),map on chromosomal regions not previously recognized as IBD-susceptibility loci.In addition, in silico clustering analysis identified 5 miRNAs (mir-26a,-29b,-126*,-127-3p,-324-3p) that share coordinated dysregulation of expression both in quiescent and in inflamed colonic mucosa of IBD patients.Six miRNAs displayed significantly distinct alteration of expression in non-inflamed colonic biopsies of UC and CD patients (mir-196b,-199a-3p,-199b-5p,-320a,-150,-223).Conclusions/Significance: Our study supports miRNAs as crucial players in the onset and/or relapse of inflammation from quiescent mucosal tissues in IBD patients.It allows speculating a role for miRNAs as contributors to IBD susceptibility and suggests that some of the miRNA with altered expression in the quiescent mucosa of IBD patients may define miRNA signatures for UC and CD and help develop new diagnostic biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
(1967) · Cited by 23,719
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,708
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,981
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,959
Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability; Vol. IV
Roy, H. L. L., Lecam, L., & Neyman, J. (1969) · Revue de l'Institut International de Statistique / Review of the International Statistical Institute · doi:10.2307/1402306 · Cited by 2,835
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
The role of site accessibility in microRNA target recognition
Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., & Segal, E. (2007) · Nature Genetics · doi:10.1038/ng2135 · Cited by 2,460 · cited 4×
“The algorithm makes use of the parameter-free model for miRNA-target interaction described by Kertesz et al. [75].”
InfluentialClassification of Inflammatory Bowel Disease
Lennard-Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,011
Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
Kaser, A., Lee, A.-H., Franke, A., Glickman, J. N., Zeissig, S., Tilg, H., Nieuwenhuis, E. E. S., Higgins, D. E., Schreiber, S., Glimcher, L. H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.021 · Cited by 1,411
the Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
MicroRNAs direct rapid deadenylation of mRNA
Wu, L., Fan, J., & Belasco, J. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510928103 · Cited by 1,138
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 884
How microRNAs control cell division, differentiation and death
Miska, E. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.005 · Cited by 819
Biological principles of microRNA-mediated regulation: shared themes amid diversity
Flynt, A. S., & Lai, E. C. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2455 · Cited by 783
Cummins, J. M., He, Y., Leary, R. J., Pagliarini, R., Diaz, L. A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A. E., Labourier, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511155103 · Cited by 744
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
the IBSEN study group, Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.221 · Cited by 591
The Genetics of Inflammatory Bowel Disease
Cho, J. H., & Weaver, C. T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.032 · Cited by 552
The UK IBD Genetics Consortium, & The Wellcome Trust Case Control Consortium 2 (2009) · Nature Genetics · doi:10.1038/ng.483 · Cited by 536
Distinctive patterns of microRNA expression in primary muscular disorders
Eisenberg, I., Eran, A., Nishino, I., Moggio, M., Lamperti, C., Amato, A. A., Lidov, H. G., Kang, P. B., North, K. N., Mitrani-Rosenbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708115104 · Cited by 514
Wu, F., Zikusoka, M., Trindade, A., Dassopoulos, T., Harris, M. L., Bayless, T. M., Brant, S. R., Chakravarti, S., & Kwon, J. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.068 · Cited by 508
Common variants at five new loci associated with early-onset inflammatory bowel disease
Western Regional Research Alliance for Pediatric IBD, Imielinski, M., International IBD Genetics Consortium, Baldassano, R. N., Griffiths, A., Russell, R. K., Annese, V., Dubinsky, M., Kugathasan, S., Bradfield, J. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.489 · Cited by 482
Kloosterman, W. P., Lagendijk, A. K., Ketting, R. F., Moulton, J. D., & Plasterk, R. H. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050203 · Cited by 464
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R. T., Chen, P., Wang, Y., Yan, M., Qian, Z., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808266105 · Cited by 457
the Wellcome Trust Case Control Consortium, Fisher, S. A., Tremelling, M., Anderson, C. A., Gwilliam, R., Bumpstead, S., Prescott, N. J., Nimmo, E. R., Massey, D., Berzuini, C., et al. (2008) · Nature Genetics · doi:10.1038/ng.145 · Cited by 424
Farmer, R. G., Easley, K. A., & Rankin, G. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01295733 · Cited by 395
miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
Gebeshuber, C. A., Zatloukal, K., & Martinez, J. (2009) · EMBO reports · doi:10.1038/embor.2009.9 · Cited by 391
Lawrance, I. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.445 · Cited by 380
Kapsimali, M., Kloosterman, W. P., de Bruijn, E., Rosa, F., Plasterk, R. H., & Wilson, S. W. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r173 · Cited by 376 · cited 1×
“…of their target mRNAs [35,36]. miRNAs are regulators of early development, cell fate determination, differentiation, proliferation, apoptosis [37–39] and dysregulation of their expression has been involved in various human diseases such as cancer [40–44], developmental abnormalities [45],…”
The genetics of inflammatory bowel disease
BONEN, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50045 · Cited by 369
Franke, A., Balschun, T., Karlsen, T. H., Hedderich, J., May, S., Lu, T., Schuldt, D., Nikolaus, S., Rosenstiel, P., Krawczak, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.148 · Cited by 352
Gomes, P., du Boulay, C., Smith, C. L., & Holdstock, G. (1986) · Gut · doi:10.1136/gut.27.1.92 · Cited by 339
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
Ferretti, E., De Smaele, E., Miele, E., Laneve, P., Po, A., Pelloni, M., Paganelli, A., Di Marcotullio, L., Caffarelli, E., Screpanti, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.172 · Cited by 332
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease
Kugathasan, S., Baldassano, R. N., Bradfield, J. P., Sleiman, P. M. A., Imielinski, M., Guthery, S. L., Cucchiara, S., Kim, C. E., Frackelton, E. C., Annaiah, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.203 · Cited by 316
Genetics of Crohn disease, an archetypal inflammatory barrier disease
Schreiber, S., Rosenstiel, P., Albrecht, M., Hampe, J., & Krawczak, M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1607 · Cited by 307
miRGen: a database for the study of animal microRNA genomic organization and function
Megraw, M., Sethupathy, P., Corda, B., & Hatzigeorgiou, A. G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl904 · Cited by 298
Moschos, S. A., Williams, A. E., Perry, M. M., Birrell, M. A., Belvisi, M. G., & Lindsay, M. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-240 · Cited by 283
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome
Zhou, Q., Souba, W. W., Croce, C. M., & Verne, G. N. (2010) · Gut · doi:10.1136/gut.2009.181834 · Cited by 277
Asano, K., Matsushita, T., Umeno, J., Hosono, N., Takahashi, A., Kawaguchi, T., Matsumoto, T., Matsui, T., Kakuta, Y., Kinouchi, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.482 · Cited by 276
Gene-Environment Interactions and Epigenetic Basis of Human Diseases
(2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.025 · Cited by 275
Xu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
The Genetics of Crohn's Disease
Van Limbergen, J., Wilson, D. C., & Satsangi, J. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150013 · Cited by 260
Intestinal permeability, leaky gut, and intestinal disorders
Hollander, D. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0023-5 · Cited by 258
Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays
Costello, C. M., Mah, N., Häsler, R., Rosenstiel, P., Waetzig, G. H., Hahn, A., Lu, T., Gurbuz, Y., Nikolaus, S., Albrecht, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020199 · Cited by 231
Allez, M., Tieng, V., Nakazawa, A., Treton, X., Pacault, V., Dulphy, N., Caillat–Zucman, S., Paul, P., Gornet, J., Douay, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.025 · Cited by 231
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
Noble, C. L., Abbas, A. R., Cornelius, J., Lees, C. W., Ho, G.-T., Toy, K., Modrusan, Z., Pal, N., Zhong, F., Chalasani, S., et al. (2008) · Gut · doi:10.1136/gut.2008.148395 · Cited by 205
New links to the pathogenesis of Crohn disease provided by genome-wide association scans
Mathew, C. G. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2203 · Cited by 203
MicroRNAs: novel regulators in skin inflammation
Sonkoly, E., Ståhle, M., & Pivarcsi, A. (2008) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2008.02804.x · Cited by 194 · cited 1×
“miRNAs are regulators of early development, cell fate determination, differentiation, proliferation, apoptosis [37–39] and dysregulation of their expression has been involved in various human diseases such as cancer [40–44], developmental abnormalities [45], muscular disorders [46] and inflammatory diseases [47–51].”
Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays
DIECKGRAEFE, B. K., STENSON, W. F., KORZENIK, J. R., SWANSON, P. E., & HARRINGTON, C. A. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.1.1 · Cited by 184
Advances in microRNAs: implications for immunity and inflammatory diseases
Sonkoly, E., & Pivarcsi, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00534.x · Cited by 183
Modelling the limit of detection in real-time quantitative PCR
Burns, M., & Valdivia, H. (2008) · European Food Research and Technology · doi:10.1007/s00217-007-0683-z · Cited by 181 · cited 1×
“The cycle number above which the CT was considered as a false positive (cycle cut-off point) was set up at 35, as already argued in the literature dealing with limits of detection in Real-Time Quantitative- RT-PCR [74] ( reviewed in [73]).”
Ahn, S.-H., Shah, Y. M., Inoue, J., Morimura, K., Kim, I., Yim, S., Lambert, G., Kurotani, R., Nagashima, K., Gonzalez, F. J., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20413 · Cited by 163
Musiyenko, A., Bitko, V., & Barik, S. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0296-9 · Cited by 162
Olsen, J., Gerds, T. A., Seidelin, J. B., Csillag, C., Bjerrum, J. T., Troelsen, J. T., & Nielsen, O. H. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20879 · Cited by 131
Larsen, R. D. (1985) · Journal of Chemical Education · doi:10.1021/ed062p302 · Cited by 103
Current status of genetics research in inflammatory bowel disease
Vermeire, S., & Rutgeerts, P. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364257 · Cited by 102
Genetics of the innate immune response in inflammatory bowel disease
Limbergen, J. V., Russell, R. K., Nimmo, E. R., Ho, G., Arnott, I. D., Wilson, D. C., & Satsangi, J. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20096 · Cited by 96
Regulation of Gene Expression in Inflammatory Bowel Disease and Correlation with IBD Drugs
Dooley, T. P., Curto, E. V., Reddy, S. P., Davis, R. L., Lambert, G. W., Wilborn, T. W., & Elson, C. O. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200401000-00001 · Cited by 91
The Genetics of Inflammatory Bowel Disease
Limbergen, J. V., Russell, R. K., Nimmo, E. R., & Satsangi, J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01527.x · Cited by 88
von Stein, P., Löfberg, R., Kuznetsov, N. V., Gielen, A. W., Persson, J., Sundberg, R., Hellstrom, K., Eriksson, A., Befrits, R., Öst, Å., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.083 · Cited by 73
Flavin, R., Smyth, P. C., Barrett, C., Russell, S., Wen, H. Y., Wei, J., Laios, A., O’Toole, S. A., Ring, M., Denning, K. M., et al. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a48cf9 · Cited by 63
Repressing the repressor: A new mode of MYC action in lymphomagenesis
Sander, S., Bullinger, L., & Wirth, T. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7599 · Cited by 37
Paavola–Sakki, P., Ollikainen, V., Heliö, T. M., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200936 · Cited by 35
Inflammatory Bowel Disease—Environmental Modification and Genetic Determinants
Kugathasan, S., & Amre, D. K. (2006) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2006.05.009 · Cited by 34
Assessing disease activity and disease activity indices for inflammatory bowel disease
Li, F. X., & Sutherland, L. R. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0025-z · Cited by 14
Cited by
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
miR‐223: infection, inflammation and cancer
Haneklaus, M., Gerlic, M., O'Neill, L. A. J., & Masters, S. L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12099 · Cited by 423
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Ventham, N. T., Kennedy, N. A., Nimmo, E. R., & Satsangi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.050 · Cited by 320
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., Simpson, D. A., Leonard, M. O., Tambuwala, M. M., Cummins, E. P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01276-10 · Cited by 289
Circulating MicroRNAs as Biomarkers for Sepsis
Benz, F., Roy, S., Trautwein, C., Roderburg, C., & Luedde, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010078 · Cited by 257
Metadata
- Authors
- Fasseu, M., Tréton, X., Guichard, C., Pedruzzi, E., Cazals-Hatem, D., Richard, C., Aparicio, T., Daniel, F., Soulé, J.-C., Moreau, R., Bouhnik, Y., Laburthe, M., Groyer, A., & Ogier-Denis, E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-10-05
- Volume
- 5
- Issue
- 10
- Pages
- e13160
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2043015183
- Cited by
- 286
- References
- 81
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.